These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23303653)

  • 1. Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.
    Kraemer HC
    Stat Med; 2013 May; 32(11):1964-73. PubMed ID: 23303653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials.
    Wallace ML; Frank E; Kraemer HC
    JAMA Psychiatry; 2013 Nov; 70(11):1241-7. PubMed ID: 24048258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors.
    McGuire JF; Ung D; Selles RR; Rahman O; Lewin AB; Murphy TK; Storch EA
    J Psychiatr Res; 2014 Nov; 58():76-83. PubMed ID: 25108618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When the patient asks. What do I do about my depression?
    Hewett ML
    JAAPA; 2010 Mar; 23(3):65. PubMed ID: 20232728
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized medicine for depression: can we match patients with treatments?
    Simon GE; Perlis RH
    Am J Psychiatry; 2010 Dec; 167(12):1445-55. PubMed ID: 20843873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications.
    Pellegrini L; Garg K; Enara A; Gottlieb DS; Wellsted D; Albert U; Laws KR; Fineberg NA
    Compr Psychiatry; 2022 Oct; 118():152339. PubMed ID: 35917621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing Personalized Medicine: Application of a Novel Statistical Method to Identify Treatment Moderators in the Coordinated Anxiety Learning and Management Study.
    Niles AN; Loerinc AG; Krull JL; Roy-Byrne P; Sullivan G; Sherbourne CD; Bystritsky A; Craske MG
    Behav Ther; 2017 Jul; 48(4):490-500. PubMed ID: 28577585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorder.
    Grilo CM; Masheb RM; Crosby RD
    J Consult Clin Psychol; 2012 Oct; 80(5):897-906. PubMed ID: 22289130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and moderators of symptom change during cognitive-behavioral therapy or supportive psychotherapy for body dysmorphic disorder.
    Phillips KA; Greenberg JL; Hoeppner SS; Weingarden H; O'Keefe S; Keshaviah A; Schoenfeld DA; Wilhelm S
    J Affect Disord; 2021 May; 287():34-40. PubMed ID: 33773357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward non-parametric and clinically meaningful moderators and mediators.
    Kraemer HC
    Stat Med; 2008 May; 27(10):1679-92. PubMed ID: 18008395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-of-1 Clinical Trials: A Scientific Approach to Personalized Medicine for Patients with Rare Retinal Diseases Such as Retinitis Pigmentosa.
    Zarbin MA; Novack G
    J Ocul Pharmacol Ther; 2021 Nov; 37(9):495-501. PubMed ID: 34491833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials.
    De Crescenzo F; Perelli F; Armando M; Vicari S
    J Affect Disord; 2014 Jan; 152-154():39-44. PubMed ID: 24139299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood maltreatment history for guiding personalized antidepressant choice in major depressive disorder: Preliminary results from a systematic review.
    Perna G; Daccò S; Alciati A; Cuniberti F; De Berardis D; Caldirola D
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110208. PubMed ID: 33338557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Designs to Optimize Treatments for Individuals: Personalized N-of-1 Trials.
    Davidson KW; Silverstein M; Cheung K; Paluch RA; Epstein LH
    JAMA Pediatr; 2021 Apr; 175(4):404-409. PubMed ID: 33587109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial.
    Menchetti M; Rucci P; Bortolotti B; Bombi A; Scocco P; Kraemer HC; Berardi D;
    Br J Psychiatry; 2014 Feb; 204(2):144-50. PubMed ID: 24311553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
    Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
    JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
    Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.